Literature DB >> 10673364

Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR.

A Sumida1, S Fukuen, I Yamamoto, H Matsuda, M Naohara, J Azuma.   

Abstract

Drug interactions which affect drug metabolism are of clinical importance. It is, however, difficult to estimate drug interactions in human from results obtained in animal experiments. In our previous study, we demonstrated that a combination of the HepG2 cell line and semiquantitative reverse transcription-PCR (RT-PCR) could be used to evaluate the degree of CYP3A mRNA induction by various drugs. Using an RT-competitive PCR (RT-cPCR) with beta-actin as the standard in this study, the constitutive and rifampicin (RFP)-induced expression of CYP3A4, CYP2C9, CYP2E1, and CYP1A2 mRNA in the HepG2 cells could be quantitatively and reproducibly determined. 120 h-treatment of HepG2 cells with 50 micromol/l RFP induced maximally 8.4- and 6.0-fold the expression of CYP3A4 and CYP2C9 mRNA, respectively, in comparison with untreated cells. On the other hand, mRNA level in CYP2E1 and CYP1A2 was not significantly changed by 50 micromol/l RFP after 24 to 120 h. To our knowledge, we report for the first time quantitative profiles of CYPs mRNA in HepG2 cells. This study demonstrates the efficiency of a combination of HepG2 cells and RT-cPCR in the evaluation of CYPs mRNA-induction by drugs. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673364     DOI: 10.1006/bbrc.1999.2029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.

Authors:  B Jian; P L Jones; Q Li; E R Mohler; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Cloning of cytochrome P-450 2C9 cDNA from human liver and its expression in CHL cells.

Authors:  Ge-Jian Zhu; Ying-Nian Yu; Xin Li; Yu-Li Qian
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 3.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug.

Authors:  Esther F A Brandon; Rolf W Sparidans; Irma Meijerman; Ignasio Manzanares; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2004-08       Impact factor: 3.850

5.  Carotenoids and their metabolites are naturally occurring activators of gene expression via the pregnane X receptor.

Authors:  Ralph Rühl; Ronny Sczech; Nico Landes; Paul Pfluger; Dirk Kluth; Florian J Schweigert
Journal:  Eur J Nutr       Date:  2004-12       Impact factor: 5.614

6.  Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress.

Authors:  Agnieszka Szuster-Ciesielska; Magdalena Mizerska-Dudka; Jadwiga Daniluk; Martyna Kandefer-Szerszeń
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

7.  Physiologically relevant oxygen tensions differentially regulate hepatotoxic responses in HepG2 cells.

Authors:  Thomas J DiProspero; Erin Dalrymple; Matthew R Lockett
Journal:  Toxicol In Vitro       Date:  2021-03-31       Impact factor: 3.685

8.  Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cells.

Authors:  Rin Nagaoka; Toshiharu Iwasaki; Nana Rokutanda; Akira Takeshita; Yukio Koibuchi; Jun Horiguchi; Noriaki Shimokawa; Yuichi Iino; Yasuo Morishita; Noriyuki Koibuchi
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

Review 9.  Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.

Authors:  M Teresa Donato; José V Castell
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 5.577

10.  Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides Do Not Induce CYP3A4 mRNA Expression.

Authors:  Maryam Modarai; Elisabete Silva; Andy Suter; Michael Heinrich; Andreas Kortenkamp
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.